Ligand Pharmaceuticals
LGND
#3476
Rank
NZ$6.96 B
Marketcap
NZ$349.08
Share price
-0.02%
Change (1 day)
85.78%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : NZ$0.95 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total liabilities are NZ$0.95 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ligand Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$0.93 B375.31%
2024-12-31NZ$0.19 B44.66%
2023-12-31NZ$0.13 B-47.55%
2022-12-31NZ$0.26 B-62.7%
2021-12-31NZ$0.69 B-22.9%
2020-12-31NZ$0.90 B-16.27%
2019-12-31NZ$1.08 B3.55%
2018-12-31NZ$1.04 B193.62%
2017-12-31NZ$0.35 B6.68%
2016-12-31NZ$0.33 B0.81%
2015-12-31NZ$0.33 B10.82%
2014-12-31NZ$0.29 B344.69%
2013-12-31NZ$67.05 M-29.08%
2012-12-31NZ$94.54 M-34.35%
2011-12-31NZ$0.14 B38.18%
2010-12-31NZ$0.10 B-45.17%
2009-12-31NZ$0.19 B-39.33%
2008-12-31NZ$0.31 B66.47%
2007-12-31NZ$0.18 B-55.61%
2006-12-31NZ$0.42 B-31.82%
2005-12-31NZ$0.62 B8.81%
2004-12-31NZ$0.57 B5.66%
2003-12-31NZ$0.54 B40.54%
2002-12-31NZ$0.38 B-8.86%
2001-12-31NZ$0.42 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$205.79 B 21,552.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$212.30 B 22,237.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$150.31 B 15,714.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$143.29 B 14,976.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$24.40 B 2,467.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$147.27 B 15,395.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$125.10 B 13,063.18%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$106.37 B 11,092.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
NZ$0.14 B-85.12%๐Ÿ‡บ๐Ÿ‡ธ USA